RT @AlanJCard: @GarethCorser @RobinD100 There have been a few studies like this. Not many, but ex: FMEA v. SWIFT: https://t.co/rLrhDi59Je…
@GarethCorser @RobinD100 There have been a few studies like this. Not many, but ex: FMEA v. SWIFT: https://t.co/rLrhDi59Je GO-ARC v. unstructured brainstorming: https://t.co/Nf5ekI1a9R ARC Toolkit v. FMEA alone: https://t.co/hBwcwroBkv Incident reports
RT @jonback: @spdegabrielle @DomFurniss @HWWPotts @StevenShorrock @annblandford what is the clinical information system used for? you need…
@spdegabrielle @DomFurniss @HWWPotts @StevenShorrock @annblandford what is the clinical information system used for? you need to study it in the context of use - This might help https://t.co/X2TUVjGI7F
RT @HWWPotts: Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
RT @HWWPotts: Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
RT @HWWPotts: Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
RT @FlopezPaco: Limitaciones de AMFE (#FMEA) y otras herramientas de Gestión de riesgos #SEGPAC. Estudio con Anticoagulantes orales. https…
Limitaciones de AMFE (#FMEA) y otras herramientas de Gestión de riesgos #SEGPAC. Estudio con Anticoagulantes orales. https://t.co/uJR4DXvuZQ
RT @HWWPotts: Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
RT @HWWPotts: Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
RT @HWWPotts: Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
Limitations of #FMEA and other prospective hazards analyses: https://t.co/2Ds0Gr2zu9 Challenges in health care... (Please RT!)
How valid is Failure Modes and Effects Analysis? #fmea Not very!https://t.co/2Ds0GqKY5z
RT @AlanJCard: .@HWWPotts @BMJ_Qual_Saf This paper is another fave of mine! https://t.co/v8zYKOnGKk #ptsafety #riskmgt #QI #FMEA #SWIFT
RT @HWWPotts: @AlanJCard @BMJ_Qual_Saf Lovely paper. We have complementary sentiments in ours on the problem with FMEA! https://t.co/2Ds0Gr…
RT @AlanJCard: .@HWWPotts @BMJ_Qual_Saf This paper is another fave of mine! https://t.co/v8zYKOnGKk #ptsafety #riskmgt #QI #FMEA #SWIFT
.@HWWPotts @BMJ_Qual_Saf This paper is another fave of mine! https://t.co/v8zYKOnGKk #ptsafety #riskmgt #QI #FMEA #SWIFT
RT @HWWPotts: @AlanJCard @BMJ_Qual_Saf Lovely paper. We have complementary sentiments in ours on the problem with FMEA! https://t.co/2Ds0Gr…
@AlanJCard @BMJ_Qual_Saf Lovely paper. We have complementary sentiments in ours on the problem with FMEA! https://t.co/2Ds0Gr2zu9
@AlanJCard Validity of FMEA/SWIFT paper published http://t.co/xKsSnOK4VA
New #patientsafety paper: http://t.co/xKsSnOK4VA "Assessing the validity of prospective hazard analysis methods" Suggests limits to #FMEA
New #patientsafety paper: http://t.co/jk4YVlVtie "Assessing the validity of prospective hazard analysis methods" Suggests limits to #FMEA